Sarka Pavlova

8PUBLICATIONS
77CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 22, 2025
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

|Dec 04, 2024
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits.

Lucie Curylova, Iva Staniczkova Zambo, Jakub Neradil

|Jul 22, 2024
Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities.

Kostas Stamatopoulos, Sarka Pavlova, Othman Al-Sawaf

|May 21, 2024
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.

Terezia Kurucova, Kamila Reblova, Pavlina Janovska

|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.

Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas

|Dec 08, 2023
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients.

Veronika Navrkalova, Karla Plevova, Lenka Radova

Pageof 2

Frequent Collaborators

6 joint publications

Sarka Pospisilova

5 joint publications

Jitka Malcikova

5 joint publications

Michael Doubek

4 joint publications

Karla Plevova